How to get the most from methotrexate (MTX) treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy
Methotrexate (MTX) is a remarkable drug with a key role in the management of rheumatoid arthritis (RA) at every stage of its evolution. Its attributes include good overall efficacy for signs and symptoms, inhibition of structural damage and preservation of function with acceptable and manageable saf...
Автори: | Taylor, P, Criado, AB, Mongey, A-B, Avouac, J, Marotte, H, Mueller, RB |
---|---|
Формат: | Journal article |
Опубліковано: |
MDPI
2019
|
Схожі ресурси
Схожі ресурси
-
Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
за авторством: Zhang L, та інші
Опубліковано: (2020-12-01) -
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
за авторством: Wulffraat NM, та інші
Опубліковано: (2011-09-01) -
International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector
за авторством: Müller-Ladner U, та інші
Опубліковано: (2024-03-01) -
Methotrexate (MTX) failed to control giant cell arteritis (GCA)
за авторством: Hoffman, G, та інші
Опубліковано: (2001) -
Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
за авторством: Jing Zhang, та інші
Опубліковано: (2020-10-01)